PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma

Published:2016-09-13 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Kanteti Rajani,Riehm Jacob J.,Dhanasingh Immanuel,Lennon Frances E.,Mirzapoiazova Tamara,Mambetsariev Bolot,Kindler Hedy L.,Salgia Ravi

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep32992.pdf

Reference45 articles.

1. Tsiouris, A. & Walesby, R. K. Malignant pleural mesothelioma: current concepts in treatment. Nat Clin Pract Oncol 4, 344–352, 10.1038/ncponc0839 (2007).

2. Sekido, Y. Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells. CancereSci 101, 1–6, 10.1111/j.1349-7006.2009.01336.x (2010).

3. De Luca, A. et al. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nat Med 3, 913–916 (1997).

4. Dogan, A. U. et al. Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. Cancer Res 66, 5063–5068, 10.1158/0008-5472.CAN-05-4642 (2006).

5. Tward, J. D., Wendland, M. M. M., Shrieve, D. C., Szabo, A. & Gaffney, D. K. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. Cancer 107, 108–115, 10.1002/cncr.21971 (2006).

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential expression of DMD transcripts as a novel prognostic biomarker in histologically diverse mesotheliomas;Translational Lung Cancer Research;2024-04

2. Emerging New Targets in Systemic Therapy for Malignant Pleural Mesothelioma;Cancers;2024-03-22

3. Melodic maestros: Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of malignant pleural mesothelioma;Pathology - Research and Practice;2023-10

4. Defining and targeting tumor-associated macrophages in malignant mesothelioma;Proceedings of the National Academy of Sciences;2023-02-23

5. Upregulation of PIK3IP1 monitors the anti-cancer activity of PI3Kα inhibitors in gastric cancer cells;Biochemical Pharmacology;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3